{"disease":{"id":"eosinophilic-esophagitis","name":"Eosinophilic esophagitis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":1,"trial_count":6},"drugs":{"marketed":[{"drug_id":"dupilumab","indication_name":"Eosinophilic esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dupixent","generic_name":"DUPILUMAB","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Interleukin-4 receptor subunit alpha","drug_class":"Interleukin-4 Receptor alpha Antagonist [EPC]","quality_score":62,"revenue":"14600","mechanism":"Dupixent blocks the interleukin-4 receptor, a key player in the immune system's inflammatory response."},{"drug_id":"budesonide","indication_name":"Eosinophilic esophagitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pulmicort Respules","generic_name":"BUDESONIDE","company_name":"AstraZeneca K.K.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":"2800","mechanism":""}],"pipeline":[{"drug_id":"cromolyn-sodium","indication_name":"Eosinophilic Esophagitis","indication_type":"pipeline","phase":"Phase 4","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CROMOLYN SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"Mast cells","drug_class":"Mast cell stabilizer","quality_score":30,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":2,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT07102329","title":"BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT02504853","title":"Natural History and Genetics of Food Allergy and Related Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03980886","title":"Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT02523118","title":"OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages","phase":"","overall_status":"RECRUITING","enrollment_count":1350,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06443346","title":"Prospective Registry of EoSinophilic esOphagitis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05896891","title":"San Raffaele EoE Biobank","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03858426","title":"Prospective Multicenter Nationwide Registry of Children With Eosinophilic Esophagitis","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Sociedad Espanola de Gastroenterologia, Hepatologia y Nutricion Pediatrica","has_results":false},{"nct_id":"NCT04753697","title":"A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT05583227","title":"Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":368,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04991935","title":"Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT06693531","title":"A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT03633617","title":"Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT02605837","title":"A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05219903","title":"National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT05246085","title":"Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04322708","title":"A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"Allakos Inc.","has_results":true},{"nct_id":"NCT02736409","title":"An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":219,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT05634746","title":"24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"Ellodi Pharmaceuticals, LP","has_results":false},{"nct_id":"NCT04543409","title":"A Study of Benralizumab in Patients With Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":211,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT02493335","title":"Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Dr. Falk Pharma GmbH","has_results":false},{"nct_id":"NCT03382678","title":"CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact Registry","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06598462","title":"A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":184,"lead_sponsor_name":"Uniquity One (UNI)","has_results":false},{"nct_id":"NCT01212016","title":"Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders","phase":"","overall_status":"TERMINATED","enrollment_count":162,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06695897","title":"A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04281108","title":"Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"Ellodi Pharmaceuticals, LP","has_results":false},{"nct_id":"NCT06501274","title":"Capsule Sponge Study in Eosinophilic Oesophagitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"East and North Hertfordshire NHS Trust","has_results":false},{"nct_id":"NCT03245840","title":"Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":133,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02778867","title":"SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT04671446","title":"Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Queen Mary University of London","has_results":true},{"nct_id":"NCT03069573","title":"Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients","phase":"","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Federal University of Uberlandia","has_results":false},{"nct_id":"NCT04682639","title":"A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03191864","title":"Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Adare Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06071585","title":"Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis","phase":"","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04394351","title":"Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT07057986","title":"Trans-Cervical and Trans-abdominal Ultrasound for Monitoring Esophageal Thickness in Eosinophilic Esophagitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT03781596","title":"EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Claire Daniels","has_results":false},{"nct_id":"NCT02098473","title":"Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT04309786","title":"Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic Esophagitis","phase":"","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT01642212","title":"OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT02434029","title":"Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Dr. Falk Pharma GmbH","has_results":false},{"nct_id":"NCT05774184","title":"A Study of CDX-0159 in Patients With Eosinophilic Esophagitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Celldex Therapeutics","has_results":false},{"nct_id":"NCT00762073","title":"Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06991881","title":"Eosinophilic Esophagitis: Towards Improved Management","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT03812575","title":"The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot)","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT06389994","title":"Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT04593251","title":"Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Calypso Biotech BV","has_results":false},{"nct_id":"NCT02434705","title":"Food Antigen in Eosinophilic Esophagitis","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04941742","title":"The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT07027826","title":"The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06101095","title":"A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":69,"lead_sponsor_name":"Sanofi","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}